C07D 213/85
In position 3
Official title: in position 3
C07D213/85 (In position 3) appears on 724 US grants and 556 published applications in this corpus.
Search patents in C07D- Granted patents
- 724
- Published applications
- 556
- Assignees
- 355
- Inventors
- 2,451
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 13 | 0 |
| 1978 | 10 | 0 |
| 1979 | 8 | 0 |
| 1980 | 23 | 0 |
| 1981 | 18 | 0 |
| 1982 | 16 | 0 |
| 1983 | 19 | 0 |
| 1984 | 16 | 0 |
| 1985 | 18 | 0 |
| 1986 | 14 | 0 |
| 1987 | 18 | 0 |
| 1988 | 5 | 0 |
| 1989 | 14 | 0 |
| 1990 | 13 | 0 |
| 1991 | 16 | 0 |
| 1992 | 13 | 0 |
| 1993 | 11 | 0 |
| 1994 | 9 | 0 |
| 1995 | 13 | 0 |
| 1996 | 12 | 0 |
| 1997 | 14 | 0 |
| 1998 | 17 | 0 |
| 1999 | 9 | 0 |
| 2000 | 10 | 0 |
| 2001 | 5 | 3 |
| 2002 | 10 | 12 |
| 2003 | 13 | 17 |
| 2004 | 11 | 42 |
| 2005 | 5 | 25 |
| 2006 | 24 | 35 |
| 2007 | 15 | 31 |
| 2008 | 16 | 35 |
| 2009 | 19 | 19 |
| 2010 | 25 | 18 |
| 2011 | 22 | 18 |
| 2012 | 13 | 12 |
| 2013 | 16 | 20 |
| 2014 | 14 | 24 |
| 2015 | 15 | 15 |
| 2016 | 22 | 20 |
| 2017 | 10 | 19 |
| 2018 | 23 | 18 |
| 2019 | 9 | 12 |
| 2020 | 13 | 21 |
| 2021 | 11 | 25 |
| 2022 | 11 | 25 |
| 2023 | 13 | 32 |
| 2024 | 13 | 20 |
| 2025 | 19 | 23 |
| 2026 | 13 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Adenosine 2A receptor modulators for use in the treatment of cancer28 Jul 2026US 12,692,255 B2Universite De Geneve
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- HSD17B13 inhibitors and uses thereof2 Jun 2026US 12,643,858 B2Inipharm, Inc.
- Heterocyclic compounds as antagonist of NMDA26 May 2026US 12,637,418 B2Takeda Pharmaceutical Company Limited
- Sik2 modulators and uses thereof17 Sep 2026US 2026/0274820 A1Nimbus Salacia, Inc.
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
- Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof9 Jul 2026US 2026/0193260 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Charged Ion Channel Blockers and Methods for Use30 Apr 2026US 2026/0116859 A1Nocion Therapeutics, Inc.
- Beta adrenergic agonist and methods of using the same23 Apr 2026US 2026/0109671 A1CuraSen Therapeutics, Inc.
Most cited
By later US patents
- Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases116US 5,006,530 ABayer Aktiengesellschaft · 1991
- Processes for preparing dianthranilate compounds and diazopyridone colorants95US 6,576,747 B1Xerox Corporation · 2003
- 2-pyridylmethylamine derivatives useful as fungicides92US 6,503,933 B1Aventis CropScience UK Limited · 2003
- Process for preparing substituted pyridone compounds91US 6,696,552 B2Xerox Corporation · 2004
- Adenosine receptor ligands and their use in the treatment of disease82US 6,586,441 B2Hoffman-La Roche Inc. · 2003